Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • ssully
    Member
    • Aug 2010
    • 48

    Computational Biology/Genomics Postdoc, to work on Malaria Genomics at NYU CGSB

    A postdoctoral position is available for a highly motivated computational biologist at the Center for Genomics and Systems Biology, in the Department of Biology at New York University. The position is part of large multi-year NIH-funded Center for the Study of Complex Malaria in India (CSCMi), a collaborative project between the laboratory of Program Director Jane Carlton at NYU and the National Institute of Malaria Research in India. The postdoctoral fellow will perform computational analyses of a variety of next generation sequence data including DNA and RNA-Seq, and involving genome assembly/annotation, variant detection/statistical verification, and genome-wide association studies. The position is an opportunity to work at the interface of genomics, infectious disease biology and global public health, and will include 1-2 trips to India per year for 2-3 weeks each.

    Applicants should have:
    (1) A detailed knowledge of next generation sequence data analysis.
    (2) Proficiency in computer programming (e.g., Unix/Linux, Perl, Python, R and/or MySQL).
    (3) An ability to work with an interdisciplinary team.
    (4) Good spoken and written English; an ability to speak Hindi and other languages such as Tamil or Gujarati is also a plus.

    Interested parties should email a CV and names of three references to Lab Manager Becca Susko at [email protected], with Carlton Lab CSCMi Position in the subject line. Applications received before 15 March 2013 will receive full consideration. The position is available immediately.

    The Carlton lab (http://cgsb.as.nyu.edu/object/JaneCarlton.html) is located in historic Greenwich Village in downtown Manhattan, New York City. NYU is one of the world’s leading research universities and the Center for Genomics and Systems Biology is housed in a new, state-of-the-art facility. The Center’s 14 faculty members study genomics and systems biology across all kingdoms of life, supported by a genome sequencing facility. For more information on the Center, see http://cgsb.as.nyu.edu/page/home.
    Last edited by ssully; 02-28-2013, 07:16 AM.
  • giantfan
    Junior Member
    • Mar 2013
    • 1

    #2
    Looks interesting sending you CV in a while

    Thanks

    ____________________
    live chat outsourcing
    Last edited by giantfan; 03-08-2013, 11:58 PM.

    Comment

    • ganter
      Junior Member
      • Jan 2014
      • 1

      #3
      This looks very interesting... I will send you my CV later

      Have a great day

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        Today, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Today, 11:10 AM
      0 responses
      8 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      30 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      38 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      25 views
      0 reactions
      Last Post SEQadmin2  
      Working...